Microcaps AG, based in Wagistrasse, Switzerland, is a cutting-edge company specializing in advanced microencapsulation technology. They recently secured CHF 9.3M (approximately €9.6M) in a Series A funding round. This funding came from new private investors as well as existing shareholders such as Helvetica Capital AG, Zürcher Kantonalbank, and the ETH Foundation. The investment will be used to enhance production facilities and continue development efforts for applications beyond fragrance.
The Swiss company plans to increase manufacturing capabilities with the goal of meeting the rising demand for their ethanol-free Perfume Pearls. This expansion will also support ongoing research and development in areas beyond cosmetics and fine fragrance applications, ensuring that Microcaps remains a leader in microencapsulation technology. Co-CEO Michael Hagander expressed excitement about the funding and its potential to expand production capacity significantly.
Microcaps was founded in 2019 by Dr. Alessandro Ofner and Michael Hagander with a focus on advanced microencapsulation solutions. The company’s mission is to revolutionize industries with innovative encapsulation solutions using technology developed from ETH Zurich’s Complex Material Group. Microcaps produces precise microcapsules and microparticles based on microfluidics, which allows for the encapsulation of active ingredients within microscopic capsules, providing precise control over release rates and improving product performance.
One of Microcaps’ flagship products, Perfume Pearls, offers long-lasting and intense fragrance that caters to a wide range of industries including pharmaceuticals, cosmetics, and food technology. The recent Series A funding will allow Microcaps to continue innovating and leading in the microencapsulation sector while showcasing strong support from shareholders in their mission to drive advancement in the industry.
In summary, Microcaps AG has secured CHF 9.3M (approximately €9.6M) through a Series A funding round led by both new private investors and existing shareholders such as Helvetica Capital AG, Zürcher Kantonalbank, and the ETH Foundation. With this funding
